AI assistant
Sending…
BioInvent International — Major Shareholding Notification 2021
Mar 23, 2021
3011_iss_2021-03-23_fa3eff41-2f2e-450a-a2a0-e5c0726beec5.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer BioInvent International Aktiebolag
Holder
Van Herk Investments B.V.
Instrument
| Instrument | Shares SE0015244520 |
|---|---|
| Before the transaction | |
| Shares | 4,848,537 |
| Voting rights | 4,848,537 |
| Transaction | |
| Reason for major shareholding notification Corporate action | |
| Date | 23/03/2021 |
| Limit for number of shares | 10 % |
| Limit for number of votes | 10 % |
| After the transaction | |
| Quantity | |
| Shares | 5,504,537 |
| Directly held voting rights | 5,504,537 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 9.41412 % |
| Directly held voting rights | 9.41412 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | 9.41412 % | 5,504,537 | |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
|||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
|||
| - Physically settled | |||
| - Cash settled | |||
| Total | 9.41412 % | 5,504,537 | |
| Chain of controlling Voting rights % Voting rights Company |
companies | ||
| 0 0 |
Van Herk Management Services B.V. |
| 0 | 0 | Aat van Herk | |
|---|---|---|---|
| Group | total holdings |
||
| Voting rights | 5,504,537 | ||
| Percentage of voting rights 9.41412 |
Published
23/03/2021 12:56

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from BioInvent International
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 29
AGM Information
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 24
Proxy Solicitation & Information Statement
2026
Mar 24
Interim / Quarterly Report
2026
Feb 26